Document is current

Article History

Accepted: 4 November 2024

First Online: 22 November 2024

Declarations

:

: The authors have no relevant financial interests to disclose. This research received no specific grant from any funding agency.

: Sagee Nissimov, Amitai Kohn, Rimona Keidar, Ayelet Livne, Mazal Shemer, Ayala Gover, Calanit Hershkovich-Shporen, Matitiahu Berkovitch, and Iris Morag declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.

: Research ethics approval for the study was obtained from Shamir Medical Center in accordance with the Declaration of Helsinki (approval number 0056-24-ASF).

: Due to the fact that dexmedetomidine has been utilized as a primary pre-LISA sedative in our unit since December 2022, informed consent for this retrospective study was waived.

: Data analyzed during this study are included in this published article as supplementary information files. Additional patients’ data are available from the corresponding author on request.

: Dr Sagee Nissimov and Prof. Iris Morag conceived, designed, and planned the study, contributed to data extraction, and interpretation of results, wrote the first and final draft of the manuscript, and approved the final publication. Drs Amitai Kohn, Rimona Keidar, Ayelet Livne, and NP Mazal Shemer assisted in the extraction of data, and contributed to and approved the final publication. Drs Ayala Gover, Calanit Hershkovich-Shporen and Prof. Matitiahu Berkovitch contributed to study design and data analysis and contributed to and approved the final publication.